Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Celis

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Frontiers in Public Health|August 29, 2024
Acceptance of a third COVID-19 vaccine dose, vaccine interchangeability, and clinical trial enrolment among parents of children 12-17 years in Lima, PerúCarlos R Celis, Lucie Ecker, Giancarlo Alvarado-Gamarra, et al.
European Journal of Pediatrics|February 20, 2026
Post-MIS-C cardiovascular outcomes: a systematic reviewGiancarlo Alvarado-Gamarra, Katherine Alcala-Marcos, Carlos R Celis, et al.
Vaccine: X|May 3, 2023
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189]Xavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, et al.
Vaccine: X|July 6, 2022
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized studyXavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Frontiers in Public Health|August 29, 2024
Acceptance of a third COVID-19 vaccine dose, vaccine interchangeability, and clinical trial enrolment among parents of children 12-17 years in Lima, PerúCarlos R Celis, Lucie Ecker, Giancarlo Alvarado-Gamarra, et al.
European Journal of Pediatrics|February 20, 2026
Post-MIS-C cardiovascular outcomes: a systematic reviewGiancarlo Alvarado-Gamarra, Katherine Alcala-Marcos, Carlos R Celis, et al.
Vaccine: X|May 3, 2023
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189]Xavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, et al.
Vaccine: X|July 6, 2022
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized studyXavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, et al.
Pageof 5